CD8A and neoplasm: We demonstrate that endogenous CD8+ T cells specific for the SPAS-1 neoantigen expand in number and are enriched in tumors following challenge with TRAMP-C2 tumor cells, and give rise to CD8+ TRM cells in diverse tissues.